These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 702700)

  • 1. Disseminated intravascular coagulation. Complication of LeVeen peritoneovenous shunts.
    Lerner RG; Nelson JC; Corines P; del Guercio LR
    JAMA; 1978 Nov; 240(19):2064-6. PubMed ID: 702700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated intravascular coagulation with the peritoneovenous shunt.
    Harmon DC; Demirjian Z; Ellman L; Fischer JE
    Ann Intern Med; 1979 May; 90(5):774-6. PubMed ID: 434678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascites-induced LeVeen shunt coagulopathy.
    Ragni MV; Lewis JH; Spero JA
    Ann Surg; 1983 Jul; 198(1):91-5. PubMed ID: 6859998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal disseminated intravascular coagulation after peritoneovenous shunt for intractable ascites.
    Matseshe JW; Beart RW; Bartholomew LG; Baldus WP
    Mayo Clin Proc; 1978 Aug; 53(8):526-8. PubMed ID: 682680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sounding boards. The LeVeen shunt for ascites and hepatorenal syndrome.
    Epstein M
    N Engl J Med; 1980 Mar; 302(11):628-30. PubMed ID: 6986021
    [No Abstract]   [Full Text] [Related]  

  • 6. Disseminated intravascular coagulation following peritoneo-venous (LeVeen) shunt.
    Gibson PR; Dudley FJ; Jakobovits AW; Salem HH; McInnes IE
    Aust N Z J Med; 1981 Feb; 11(1):8-12. PubMed ID: 6941784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early complications and long-term results of the LeVeen peritoneo-venous shunt in the treatment of refractory ascites].
    Arciero G; Di Blasio V; Botta V; Rossi M; Pigna F; Di Tora A
    Minerva Chir; 1996 Nov; 51(11):897-901. PubMed ID: 9072716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneovenous shunting for ascites.
    Puig JG; Antón FM; Fernández FA; Aguado AG; Rodriguez JJ
    N Engl J Med; 1980 Aug; 303(8):461. PubMed ID: 7393280
    [No Abstract]   [Full Text] [Related]  

  • 9. Ascites, the LeVeen shunt, and endotoxin.
    Buhac I
    Ann Intern Med; 1980 Apr; 92(4):572. PubMed ID: 7362172
    [No Abstract]   [Full Text] [Related]  

  • 10. Peritoneovenous shunts palliate malignant ascites.
    Edney JA; Hill A; Armstrong D
    Am J Surg; 1989 Dec; 158(6):598-601. PubMed ID: 2480068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal pulmonary tumor embolization following peritoneovenous shunting for malignant ascites.
    Smith RR; Sternberg SS; Paglia MA; Golbey RB
    J Surg Oncol; 1981; 16(1):27-35. PubMed ID: 6257978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombocytopenia and laboratory evidence of disseminated intravascular coagulation after shunts for ascites in malignant disease.
    Tempero MA; Davis RB; Reed E; Edney J
    Cancer; 1985 Jun; 55(11):2718-21. PubMed ID: 3995480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morbidity and mortality after peritoneovenous shunt surgery for refractory ascites.
    Rubinstein D; McInnes I; Dudley F
    Gut; 1985 Oct; 26(10):1070-3. PubMed ID: 4054706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulopathy of peritoneovenous shunts: studies on the pathogenic role of ascitic fluid collagen and value of antiplatelet therapy.
    Salem HH; Dudley FJ; Merrett A; Perkin J; Firkin BG
    Gut; 1983 May; 24(5):412-7. PubMed ID: 6840615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneovenous shunting in the management of malignant ascites.
    Straus AK; Roseman DL; Shapiro TM
    Arch Surg; 1979 Apr; 114(4):489-91. PubMed ID: 86345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneovenous shunting for ascites in cancer patients.
    Oosterlee J
    Br J Surg; 1980 Sep; 67(9):663-6. PubMed ID: 6159041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe coagulopathy following insertion of the LeVeen shunt: a potentially fatal complication.
    Lewis RT
    Can J Surg; 1979 Jul; 22(4):361-3. PubMed ID: 455166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The aggregation of human platelets by ascitic fluid: a possible mechanism for disseminated intravascular coagulation complicating LeVeen shunts.
    Salem HH; Koutts J; Handley C; van Der Weyden MB; Dudley FJ; Firkin BG
    Am J Hematol; 1981 Sep; 11(2):153-7. PubMed ID: 6272573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the genesis of diffuse intravascular coagulation after implantation of a peritoneal-jugular le veen shunt (author's transl)].
    Murr H; Grunst J; Eisenburg J; Hiller E; Zumtobel V
    Klin Wochenschr; 1980 Jan; 58(2):85-90. PubMed ID: 7366121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procoagulant activity of ascitic fluid in hepatic cirrhosis: in vivo and in vitro.
    Phillips LL; Rodgers JB
    Surgery; 1979 Nov; 86(5):714-21. PubMed ID: 494063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.